Copyright © 1994 by the European Society of Cardiology.
© 1994 The European Society of Cardiology
Quantification of β-Adrenoceptors and β-Adrenoceptor Kinase on Protein and mRNA Levels in Heart Failure

* Klinik III für Innere Medizin der Universität zu Köln Köln, Germany
Laboratorium für Molekulare Biologie der Universität München Germany
Correspondence: PD Dr M. Böhm, Klinik III für Innere Medizin der Universität zu Köln. Joseph-Stelzmann-Str. 9,50924 Köln, Germany
The alterations of the β-adrenoceptor adenylyl cyclase are reviewed. In failing myocardium, the down-regulation of β1adrenoceptors is accompanied by a decrease in steady state mRNA levels, as studied with quantitative polymerase chain reactions in dilated and ischaemic cardiomyopathy. The density of β2-adrenoceptors and β2-adrenoceptor mRNA was unchanged in both pathological conditions compared to non-failing myocardium. In addition to down-regulation of β1-receptor protein and mRNA, an increased activity of the β-adrenoceptor kinase (p-ARK) was observed. Correspondingly, quantification of P-ARK mRNA by a 5' and a middle portion PCR-product suggests that increased enzyme activity could be due to increased transcription. In summary, decreased steady state levels of β1-adrenoceptor mRNA could contribute to reduced β-adrenoceptor density in failing myocardium. The known uncoupling of β-adrenoceptors could be due to an increased mRNA expression and activity of β-ARK.
Key Words: Human myocardium heart failure β-adrenoceptors G-proteins β-adrenoceptor kinase polymerase chain reaction
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Pandya, K. Porter, H. A. Rockman, and O. Smithies Decreased beta-adrenergic responsiveness following hypertrophy occurs only in cardiomyocytes that also re-express beta-myosin heavy chain Eur J Heart Fail, July 1, 2009; 11(7): 648 - 652. [Abstract] [Full Text] [PDF] |
||||
